Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study.
Yves Habimana-MucyoAugustin DushimePatrick MigambiInnocent HabiyambereJean Claude Semuto NgabonzizaTom DecrooPublished in: International health (2022)
High rifampicin DST coverage for routine reporting allowed Rwanda to estimate the RR-TB prevalence among new and previously treated patients.
Keyphrases
- drug resistant
- mycobacterium tuberculosis
- multidrug resistant
- end stage renal disease
- newly diagnosed
- acinetobacter baumannii
- chronic kidney disease
- ejection fraction
- risk factors
- prognostic factors
- healthcare
- emergency department
- pseudomonas aeruginosa
- pulmonary tuberculosis
- cystic fibrosis
- adverse drug
- health insurance
- electronic health record